NXTM stock forecast
Our latest prediction for NxStage Medical, Inc.'s stock price was made on the April 20, 2017 when the stock price was at 28.09$.
In the short term (2weeks), NXTM's stock price should outperform the market by 0.20%. During that period the price should oscillate between -4.99% and +5.42%.
In the medium term (3months), NXTM's stock price should underperform the market by -1.01%. During that period the price should oscillate between -12.59% and +13.47%.Get email alerts
About NxStage Medical, Inc.
Develops, manufactures and markets products for the treatment of kidney failure and related diseases
At the moment the company generates 426M USD in revenues.
On its last earning announcement, the company reported a loss of -0.08$ per share.
The book value per share is 3.37$
Three months stock forecastApril 20, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|